Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ACRX

AcelRx

$4.29

0.34 (8.61%)

16:03
10/15/18
10/15
16:03
10/15/18
16:03
Hot Stocks
AcelRx: DSUVIA efficacy and safety data to be presented at ASA »

AcelRx Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

ACRX

AcelRx

$4.37

0.42 (10.63%)

12:30
10/15/18
10/15
12:30
10/15/18
12:30
Recommendations
AcelRx analyst commentary at H.C. Wainwright »

H.C. Wainwright sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

ABCD

Cambium Learning

$12.05

0.27 (2.29%)

, TNDM

TNDM

09:12
10/15/18
10/15
09:12
10/15/18
09:12
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Cambium Learning…

ABCD

Cambium Learning

$12.05

0.27 (2.29%)

TNDM

TNDM

ACRX

AcelRx

$3.95

(0.00%)

HRS

Harris

$154.88

0.61 (0.40%)

LLL

L3 Technologies

$195.99

0.74 (0.38%)

PGNX

Progenics

$5.55

-0.035 (-0.63%)

BAC

Bank of America

$28.42

0.07 (0.25%)

AAXN

Axon

$58.91

2.7 (4.80%)

NTRI

Nutrisystem

$37.12

1.11 (3.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 24

    Oct

  • 29

    Oct

  • 03

    Nov

  • 27

    Nov

ACRX

AcelRx

$3.95

(0.00%)

08:45
10/15/18
10/15
08:45
10/15/18
08:45
Recommendations
AcelRx analyst commentary at Cantor Fitzgerald »

AcelRx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

ACRX

AcelRx

$3.95

(0.00%)

06:12
10/15/18
10/15
06:12
10/15/18
06:12
Upgrade
AcelRx rating change at Jefferies »

AcelRx upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

Friday
ACRX

AcelRx

$3.95

(0.00%)

16:45
10/12/18
10/12
16:45
10/12/18
16:45
Hot Stocks
Breaking Hot Stocks news story on AcelRx 

AcelRx trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 03

    Nov

ACRX

AcelRx

$3.95

(0.00%)

16:17
10/12/18
10/12
16:17
10/12/18
16:17
Hot Stocks
AcelRx says FDA advisory committee recommeds approval of Dsuvia »

AcelRx Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 03

    Nov

ACRX

AcelRx

$3.95

(0.00%)

14:56
10/12/18
10/12
14:56
10/12/18
14:56
Hot Stocks
FDA advisors vote 10-3 in favor of backing approval of AcelRx's Dsuvia »

Members of an FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 03

    Nov

ACRX

AcelRx

$3.95

0.35 (9.72%)

07:11
10/12/18
10/12
07:11
10/12/18
07:11
Hot Stocks
AcelRx stock trading halted; FDA Advisory committee to review DSUVIA NDA »

AcelRx Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 03

    Nov

ACRX

AcelRx

$3.95

0.35 (9.72%)

06:55
10/12/18
10/12
06:55
10/12/18
06:55
Hot Stocks
Breaking Hot Stocks news story on AcelRx »

AcelRx trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 03

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.